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Coupling of Steroid Hormones t o  
Biodegradable Poly(a-amino acids) I: 
Norethindrone Coupled t o  
Poly-N5- (3-hydroxypropyl) -L-glutamine 
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to norethindrone, controlled release of norethindrone from coupled 
compounds 
To the Editor: 
Sustained release of drugs from polymeric matrixes has 
received increased interest (1-5). Hormone release from 
such systems was investigated to obtain devices for long- 
term contraceptive purposes. A new approach in the re- 
lease of hormones from polymeric systems is the use of 
covalently bound polymer-hormone compounds that are 
biodegradable and do not need removal after implantation. 
Although a few examples of steroids being bonded cova- 
lently to polymers have been reported (6-8), the coupling 
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of steroids to Biodegradable polymers was presentee. only 
recently (9). Ve wish to report a new derivatization of 
17a-ethynyl-17P-hydroxy steroids, which are appropriate 
for attachment to biodegradable poly( a-amino acids). 
Poly(hydroxyalky1)-L-glutamines (111) were studied by 
several investigators (10, Iij .  These polymers are prepared 
through the base-catalyzed polymerization of y-ben- 
zyl-L-glutamate N-carboxyanhydride (I), giving the 
polymeric benzyl-L-glutamate (II), followed by displace- 
ment of the benzyl group with the desired hydroxyalkyl 
amines (12) (Scheme I). The polymers are water soluble 
but become water insoluble upon substitution with hy- 
drophobic steroids. 
The steroid selected for derivatization was norethin- 
drone (IV), an active progestin (Scheme 11). Reaction of 
IV in methylene chloride with a stoichiometric amount of 
pyridine and an excess of phosgene at  room temperature 
resulted in a 77% yield of norethindrone-17/3-chlorofor- 
mate (V, mp 103-105" dec.). The reaction was monitored 
by TLC until IV had disappeared completely. The struc- 
ture of V then was verified; IR (v, KBr pellet): 1780 
(chloroformate) cm-'; 'H-NMR (6, CDC13): 5.80 (s, lH,  
4l), 2.77 (s, lH, 21), and 1.00 (s, 3H, 18). 
Compound V is unstable and was derivatized to further 
confirm its structure and to investigate its potential for the 
coupling with polymer IIIa. Compound V was reacted with 
These numbers correspond to the standard nomenclature for carbon atoms of 
the steroid skeleton to which the protons are attached. The carbonate carbon is 
number 22, and the alkyl groups of the carbonate esters are numbered from 23 to 
28, where 28 is the terminal carbon of the hexylcarbonate (VII). 
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a stoichiometric amount of pyridine and excess methanol 
or hexanol in dichloromethane to give norethindrone- 
17@-methylcarbonate (VI, 84% yield, mp 153-154”) or 
norethindrone-176-hexylcarbonate (VII, 94% yield, oil). 
The spectroscopic data for VI were: IR (Y, KBr pellet): 
1750 (carbonate) cm-’; ‘H-NMR (6, CDCl3): 5.80 (s, lH,  
4), 3.77 (s, 3H, 23), 2.63 (s, lH,  2l), and 0.97 (s, 3H, 18); 
mass spectrum: mle 356 (loo%, M+) and 342 (4.17, M+ - 
CH3); satisfactory combustion analysis was obtained. The 
spectroscopic data for VII were: IR (v, oil film): 1750 
(carbonate) cm-l; ‘H-NMR (CDC13): 6 5.80 (s, lH,  4), 4.10 
(t, 2H, 23), 2.63 (s, lH, 21), 0.95 (s, 3H, 181, and 0.86 (t, 3H, 
28); mass spectrum: mle 426 (3.594 M+) and 342 [45, M+ 
- (CH2)&H31. 
It has been claimed that a base is not necessary for the 
conversion of primary alcohols into their chloroformates. 
When tertiary alcohols are converted to their chlorofor- 
mates, a base is required (13). To check whether a selective 
reaction with a primary alcohol group in derivatized IV 
(e.g., the 3-oxime derivative) would be possible, noreth- 
indrone (IV) was reacted with phosgene in the absence of 
pyridine. As anticipated, no chloroformate was formed. 
Coupling reactions to poly-N5-(3-hydroxypropyl)-~- 
glutamine were monitored using tritiated norethindrone2. 
Compound IIIa3 was dried for 5 days under high vacuum 
at  room temperature, dissolved in a mixture of anhydrous 
dimethylformamide and pyridine, and then reacted with 
the tritiated V, which was synthesized as described. The 
polymer was isolated from unreacted products by repeated 
precipitation in ethyl acetate. 
The degree of substitution of norethindrone onto the 
available hydroxyl groups of IIIa was up to 60% as deter- 
mined by liquid scintillation counting techniques. The 
following spectroscopic data were obtained: IR (v, mineral 
oil): 1760 and 1265 (carbonate) cm-l, 1660 and 1550 
(amide) cm-’, and 3300 (hydroxyl) cm-’. 
In uiuo release studies using norethindrone coupled to 
poly-N5-(3-hydroxypropyl)-~-glutamine microparticles, 
which were implanted subcutaneously in rats, showed a 
near zero-order release rate for >200 days (14). 
2 Nonspecific tritiated norethindrone, New England Nuclear, Boston, MA 
3 Obtained from poly(y-benzyl-L-Rlutamate), which had a viscosity average 
02118. 
molecular weight of 53,000. 
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